NEW YORK, Feb 15 – Genomic Solutions reported Thursday fourth quarter 2000 earnings of $5.5 million, up from $3.4 million in the same quarter of 1999, as the result of increased sales of the Investigator proteomic and GeneTAC biochip system and revenues from contract research performed at the company’s Proteomic Research Center.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.